# A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males

> **NCT07025915** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Shenyang Sunshine Pharmaceutical Co., LTD.** · enrollment: 6 (estimated)

## Conditions studied

- Healthy Subjects (HS)

## Interventions

- **DRUG:** [14C]SSS17

## Key facts

- **NCT ID:** NCT07025915
- **Lead sponsor:** Shenyang Sunshine Pharmaceutical Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07025915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07025915, "A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07025915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*